Upgrade to SI Premium - Free Trial

Moderna (MRNA) Stock Pops on New Buyback Program, Goldman Sachs Sees More Vaccine Contracts for 2022 and 2023

February 24, 2022 9:09 AM
Shares of Moderna (NASDAQ: MRNA) are up over 2% in premarket trading Thursday after the company reported better-than-expected Q4 results ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Earnings Guidance Hot Earnings Stock Buybacks

Next Articles